Return to search results
BARDA CBRN Medical Countermeasure Portfolio
BARDA Chemical, Biological, Radiological, and Nuclear medical countermeasure portfolio data. The public JSON feed currently contains 134 portfolio products. CBRN branches represented include Antimicrobials, Antivirals & Antitoxins, Burn & Blast, Chemical, Other, Rad/Nuc, Vaccines. Impact areas represented include Combination Product, Devices, Enabling Technologies, Other, Therapeutics, Vaccines.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | Dataset |
|---|---|
| accessRights | public |
| contactPoint |
[ { "fn": "BDR Administrative Inbox", "@type": "Kind", "hasEmail": "mailto:BDR_Admin_Inbox@hhs.gov" } ] |
| description | BARDA Chemical, Biological, Radiological, and Nuclear medical countermeasure portfolio data. The public JSON feed currently contains 134 portfolio products. CBRN branches represented include Antimicrobials, Antivirals & Antitoxins, Burn & Blast, Chemical, Other, Rad/Nuc, Vaccines. Impact areas represented include Combination Product, Devices, Enabling Technologies, Other, Therapeutics, Vaccines. |
| distribution |
[ { "@type": "Distribution", "title": "BARDA CBRN Medical Countermeasure Portfolio JSON Data", "format": "JSON", "mediaType": "application/json", "description": "Public JSON data feed backing the MedicalCountermeasures.gov page.", "downloadURL": "https://medicalcountermeasures.gov/app/cbrn/getdata", "accessRestriction": [ { "@type": "AccessRestriction", "restrictionStatus": "Unrestricted" } ] } ] |
| identifier | https://medicalcountermeasures.gov/barda/cbrn#portfolio |
| inventoried | 2026-09-27 |
| keyword |
[ "361 Product (HCT/P)", "AMR Bacteria", "ASPR", "Anthrax", "Antimicrobials", "Antivirals & Antitoxins", "Approved", "BARDA", "Botulism", "Burn & Blast", "CBRN", "COVID-19", "Chemical", "Cleared", "Combination Product", "Devices", "Enabling Technologies", "Filoviruses", "Fungi", "Licensed", "MedicalCountermeasures.gov", "Nuclear Detonation", "Other", "Phase 1", "Phase 1/2", "Phase 2", "Phase 2/3", "Phase 3", "Pre-clinical", "Project BioShield", "Rad/Nuc", "Radiological", "Smallpox", "Therapeutic Platforms", "Therapeutics", "Vaccines", "biological threats", "chemical threats", "medical countermeasures", "nuclear threats", "portfolio", "public health emergencies", "radiological threats" ] |
| landingPage |
{ "@type": "Document", "title": "BARDA CBRN Medical Countermeasure Portfolio", "accessURL": "https://medicalcountermeasures.gov/barda/cbrn#portfolio" } |
| modified | 2026-06-18 |
| publisher |
{ "name": "Biomedical Advanced Research and Development Authority (BARDA)", "@type": "Organization", "subOrganizationOf": [ { "name": "Administration for Strategic Preparedness and Response (ASPR)", "@type": "Organization", "subOrganizationOf": [ { "name": "U.S. Department of Health and Human Services", "@type": "Organization" } ] } ] } |
| theme |
[ { "@type": "Concept", "prefLabel": "Health; Emergency Preparedness; Medical Countermeasures" } ] |
| title | BARDA CBRN Medical Countermeasure Portfolio |
